Evidence map›Paper›PMID 41803186›Full record

ArticleScientific reports2026

Small RNA sequencing analysis identified miR159a as a novel candidate for activity in plant-derived nanovesicles from limon, hassaku, and sudachi.

Hideki Takakura, Shingo Miyamoto, Tetsushi Yamamoto, Toshimasa Nakao, Atsushi Taga, Michihiro Mutoh, Keisuke Oda

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hideki TakakuraLaboratory of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hiroshima International University, Hiroshima, 737 - 0112, Japan. takakura@hirokoku-u.ac.jp.
Shingo MiyamotoDepartment of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Tetsushi YamamotoPathological and Biomolecule Analyses Laboratory, Faculty of Pharmacy, Kindai University, Osaka, 577-8502, Japan.
Toshimasa NakaoDivision of Renal Surgery and Transplantation, Jichi Medical University, Shimotsuke, Tochigi, Japan.
Atsushi TagaPathological and Biomolecule Analyses Laboratory, Faculty of Pharmacy, Kindai University, Osaka, 577-8502, Japan.
Michihiro MutohDepartment of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Keisuke OdaLaboratory of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hiroshima International University, Hiroshima, 737 - 0112, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Owing to their safety, plant-derived nanovesicles (PDNVs), particularly those derived from edible plants, are expected to be natural delivery carriers for microRNAs (miRNAs). Among PDNVs, Citrus limon-derived extracellular vesicle-like nanovesicles have been shown to exert antitumor effects. We previously reported that PDNVs derived from C. limon L. exert selective inhibitory effects on the proliferation of p53-inactivated colon cancer cells. However, miRNAs in C. limon L.-derived nanovesicles have not yet been identified, and it remains unclear which miRNAs are contained in these PDNVs. We herein extracted PDNVs from C. limon L., C. hassaku, and C. sudachi and identified and compared the miRNAs present within them via next-generation sequencing. A total of 158 miRNAs were identified, of which 109 were known miRNAs and 49 were novel miRNAs. Comparisons of miRNAs expressed by C. limon L., C. hassaku, and C. sudachi revealed 77 miRNAs that were commonly expressed. Among all the libraries, miR159a had the highest number of reads, and the same result was obtained when it was converted to TPM. The present results raise the possibility that miR159a could be involved in the biological properties of citrus‑derived nanovesicles, given that it was the most abundantly expressed miRNA.

Indexed as

CitrusExtracellular VesiclesMicroRNAsRNA, PlantHigh-Throughput Nucleotide SequencingSequence Analysis, RNAMicroRNAsRNA, PlantmiR159amiRNAPlant-derived nanovesicles

Identifiers

PMID41803186
PMCPMC12979852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.